Clinical Trials

PRISM

PRecISion Medicine for Children with Cancer

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Hodgkin Lymphoma, Kidney (Renal) Tumours, Leukaemia, Liver tumours, Neuroblastoma, Non-Hodgkin Lymphoma, Soft Tissue Sarcomas

Status: Open | NSW , QLD , SA , TAS , VIC , WA

This study aims to see if a personalised approach can be used to find treatment options for children with high-risk cancer by analysing each child’s cancer using a range of different models. Also, the study seeks to understand the psychological impact of participation in a personalised cancer medicine study, and to analyse the costs and benefits of the personalised approach to manage high-risk cancers. Researchers will also be examining whether there are heritable genetic variants that increase the risk of developing cancer at a young age.

Disease Stage: Initial diagnosis/relapse

Patient Age Range: <21 years

Sample Size: Approximately 250

Trial Sponsors:

  • National: ANZCHOG

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168